CRMD vs MDLZ · P/E 3.9, rev $43.5M vs P/E 30, rev $38.54B
CorMedix Inc (CRMD) versus Mondelez International Inc (MDLZ) — a side-by-side from cached financials, not a winner call.
CorMedix Inc (CRMD) is a biotechnology company listed on US.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Latest reported CRMD revenue for 2024-12-31 was $43.5M. Net income was -$17.9M. Revenue was up 66363.1% from 2022-12-31 to 2024-12-31. CRMD currently screens at market cap $655.9M and trailing P/E 3.9.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
CRMD currently screens at market cap $655.9M and trailing P/E 3.9. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Not investment advice. Open the CRMD and MDLZ stock pages for the full models.
Not investment advice.